Latest Product
C2 CryoBalloon™ Ablation
ELEVATING ABLATION.
EXCEEDING EXPECTATIONS.
A vital part of your comprehensive offering for patients with Barrett's esophagus with dysplasia [1,2].
Patients experienced less post-procedure pain and need for narcotic medication [4].
Highly effective and durable response through 2 years:
1-year results: 95% CED 88% CEIM [2,3] | 2-year results: 95% CED 90%CEIM
| ![]() |
Ready to ablate a wide range of patients
| ![]() | ![]() |
| C2 CryoBalloon™ 90° Standard Catheter ablating treatment naive tissue | C2 CryoBalloon™ Focal Pear Catheter at GEJ
|
![]() |
To discover the full C2 CryoBalloon™ experience click here.
1. Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, et al. Development of quality indicators for endoscopic eradication therapies in Barrett’s esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium. Am J Gastroenterol. 2017;112(7):1032-1048.
2. Canto MI, Shaheen NJ, Almario JA, Voltaggio L, Montgomery E, Lightdale CJ. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett’s esophagus (with video). Gastrointest Endosc. 2018. [Epub ahead of print]
3. Canto MI. Safety, efficacy, and durability of endoscopic nitrous oxide cryoballoon ablation for eradication of Barrett’s neoplasia. Poster to be presented at: Digestive Disease Week; June 2-5, 2018. Washington, DC.
4. Van Munster SN, Overwater A, Haidry R, Bisschops R, Bergman J, Weusten BL. CryoBalloon ablation of dysplastic Barrett’s esophagus causes shorter duration and less severe post-procedural pain as compared to radiofrequency ablation. Oral presentation to be presented at: Digestive Disease Week; June 2-5, 2018. Washington, DC.
Product Details
News
HOYA Corporation acquires the remaining stake of WASSENBURG Medical B.V.
Tokyo, Japan – 22nd November 2023 HOYA Corporation (HOYA) today acquired the remaining 49% of the shares of WASSENBURG Medical B.V (WASSENBURG), becoming the sole shareholder of the Dutchbased medical reprocessing company. WASSENBURG Medical is a global manufacturer of a complete range of systems, consumables and services covering all aspects of the endoscope reprocessing cycle. Completing this transaction will provide for further innovation in reprocessing of endoscopes solutions by combining the engineering power of WASSENBURG Medical and the flexible endoscopy division PENTAX Medical. “The strategic alliance formed between HOYA and WASSENBURG has provided for a strong platform of growth since 2013. WASSENBURG has more than doubled its turnover and opened additional direct affiliates in Europe and most recently in the United States, providing a platform for strong further growth. We are also delighted that Arno and Ronald Wassenburg, the Presidents of WASSENBURG, have agreed to continue leading WASSENBURG Medical in close cooperation with the PENTAX Medical team and other HOYA MedTech & Life Science divisions.” said Eiichiro IKEDA CEO of HOYA Corporation. “Being a member of HOYA has driven us to accelerate innovation and expansion into new markets across the globe.” said Arno Wassenburg and Ronald Wassenburg commented “Having continued access to all the MedTech & Life Science divisions and related technology, while enjoying cooperation among these divisions, will provide for the foundation of designing the next platform in flexible endoscopy reprocessing solutions.” “We are excited about the acquisition, allowing us to work even closer with our partners in the WASSENBURG team.” said Rainer Burkard, President of PENTAX Medical. “Combining innovations like the recently launched AquaTYPHOON™, a device providing for automated brushless endoscope channels pre-cleaning, with the smart, safe and high-end-quality washer-disinfectors of WASSENBURG will provide for unmatched reprocessing solutions in endoscopy.”
About WASSENBURG Medical
Wassenburg Medical B.V., originally a family company, was established in 1984 by Gerrit Wassenburg and has developed into a highly regarded specialist in all aspects of automated endoscope reprocessing. The Vision of Wassenburg Medical is to provide for every patient a safe endoscope, while the ultimate goal is infection-free patient treatment and a safe, user friendly, efficient, and innovative endoscope reprocessing process at every hospital or clinic. At Wassenburg, we are passionate about designing and delivering safe and innovative products and services. We want to raise the bar and the standards within the international endoscope reprocessing industry.
For more information: http://www.wassenburgmedical.com
About PENTAX Medical
PENTAX Medical is a division of HOYA Group. The company’s mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. PENTAX Medical strives to align with the healthcare community’s Triple Aim goals through transparent partnerships with its customers and by providing the highest quality solutions to help them reach their goals, including enabling customers to improve patient outcomes by offering evidence-based solutions across the continuum of care; ensuring value by supporting the customers to improve their efficiency and minimize their healthcare costs; and enriching patient and provider’s experience by empowering every member of the care team to achieve optimal outcomes through products, education, and support. Focused on the outcome instead of technological features, PENTAX Medical listens to the healthcare community and their patients, understands their daily obstacles and helps improve endoscopy with smart innovations.
For more information: http://www.pentaxmedical.com
About HOYA
Founded in 1941 in Tokyo, Japan, HOYA Corporation is a global technology and med-tech company and a leading supplier of innovative high-tech and medical products. HOYA is active in the fields of lifecare and information technology, providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses, as well as key components for semiconductor devices, LCD panels, and hard disk drives. With over 150 offices and subsidiaries worldwide, HOYA currently employs a multinational workforce of 36,000 people. For more information, please visit: http://www.hoya.com.
More

Read our Blog
PENTAX INSIGHT EDUCATION: CASE REPORTS
PENTAX Medical is committed to continuing to be a true partner in education and innovation. That’s why we’re pleased to present the PENTAX INSIGHT Studio Case Reports.
Posted Dec 20, 2022
More